COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…
Dr. Jay Greenstein, CEO of Embody Health, joins the Disruption/Interruption podcast to discuss how fusing AI with behavioral science and…
New multi-modal GenAI solution accelerates report authoring and introduces breakthrough "Figures-to-Text" interpretation for faster, context-aware clinical insights CAMPBELL, Calif., Oct.…
Gross proceeds from sales of shares amounting to $4.5 million and exercise of warrants providing a further $2.7 millionTotal gross…
Collaboration will leverage the exchange of expertise, develop innovative supply-chain models, and assess technology-driven solutions to improve product availability Strategic…
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000…
COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby…
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- ObvioHealth, a global leader in digital clinical trial solutions, announced that it has signed…
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for…
Policy opinion leaders believe a biological attack is both more likely and easier to execute than a nuclear strike, highlighting…